The global market for Sickle Cell Disease Diagnosis and Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Sickle Cell Disease Diagnosis and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Disease Diagnosis and Treatment.

The Sickle Cell Disease Diagnosis and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sickle Cell Disease Diagnosis and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sickle Cell Disease Diagnosis and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sickle Cell Disease Diagnosis and Treatment Market Report

Report Metric	Details
Report Name	Sickle Cell Disease Diagnosis and Treatment Market
CAGR	5%
Segment by Type	Diagnosis Treatment
Segment by Application	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Disease Diagnosis and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The main players in the Sickle Cell Disease Diagnosis and Treatment Market are Emmaus Medical, Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The Applications covered in the Sickle Cell Disease Diagnosis and Treatment Market report are Child, Adult

What are the Type segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

Ans: The Types covered in the Sickle Cell Disease Diagnosis and Treatment Market report are Diagnosis, Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Diagnosis

1.2.3 Treatment

1.3 Market by Application

1.3.1 Global Sickle Cell Disease Diagnosis and Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Child

1.3.3 Adult

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Perspective (2020-2031)

2.2 Global Sickle Cell Disease Diagnosis and Treatment Growth Trends by Region

2.2.1 Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Region (2020-2025)

2.2.3 Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2026-2031)

2.3 Sickle Cell Disease Diagnosis and Treatment Market Dynamics

2.3.1 Sickle Cell Disease Diagnosis and Treatment Industry Trends

2.3.2 Sickle Cell Disease Diagnosis and Treatment Market Drivers

2.3.3 Sickle Cell Disease Diagnosis and Treatment Market Challenges

2.3.4 Sickle Cell Disease Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue

3.1.1 Global Top Sickle Cell Disease Diagnosis and Treatment Players by Revenue (2020-2025)

3.1.2 Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Sickle Cell Disease Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sickle Cell Disease Diagnosis and Treatment Revenue

3.4 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio

3.4.1 Global Sickle Cell Disease Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Diagnosis and Treatment Revenue in 2024

3.5 Global Key Players of Sickle Cell Disease Diagnosis and Treatment Head office and Area Served

3.6 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application

3.7 Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Type

4.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Type (2020-2025)

4.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2026-2031)

5 Sickle Cell Disease Diagnosis and Treatment Breakdown Data by Application

5.1 Global Sickle Cell Disease Diagnosis and Treatment Historic Market Size by Application (2020-2025)

5.2 Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)

6.2 North America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)

6.4 North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)

7.2 Europe Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)

7.4 Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)

8.2 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)

9.2 Latin America Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)

9.4 Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size (2020-2031)

10.2 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emmaus Medical

11.1.1 Emmaus Medical Company Details

11.1.2 Emmaus Medical Business Overview

11.1.3 Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Introduction

11.1.4 Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.1.5 Emmaus Medical Recent Development

11.2 Addmedica

11.2.1 Addmedica Company Details

11.2.2 Addmedica Business Overview

11.2.3 Addmedica Sickle Cell Disease Diagnosis and Treatment Introduction

11.2.4 Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.2.5 Addmedica Recent Development

11.3 Gamida Cell

11.3.1 Gamida Cell Company Details

11.3.2 Gamida Cell Business Overview

11.3.3 Gamida Cell Sickle Cell Disease Diagnosis and Treatment Introduction

11.3.4 Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.3.5 Gamida Cell Recent Development

11.4 GlycoMimetics

11.4.1 GlycoMimetics Company Details

11.4.2 GlycoMimetics Business Overview

11.4.3 GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Introduction

11.4.4 GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.4.5 GlycoMimetics Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Sickle Cell Disease Diagnosis and Treatment Introduction

11.5.4 Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Sickle Cell Disease Diagnosis and Treatment Introduction

11.6.4 Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Global Blood Therapeutics

11.7.1 Global Blood Therapeutics Company Details

11.7.2 Global Blood Therapeutics Business Overview

11.7.3 Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction

11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.7.5 Global Blood Therapeutics Recent Development

11.8 Micelle BioPharma

11.8.1 Micelle BioPharma Company Details

11.8.2 Micelle BioPharma Business Overview

11.8.3 Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Introduction

11.8.4 Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.8.5 Micelle BioPharma Recent Development

11.9 Bluebird Bio

11.9.1 Bluebird Bio Company Details

11.9.2 Bluebird Bio Business Overview

11.9.3 Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Introduction

11.9.4 Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.9.5 Bluebird Bio Recent Development

11.10 Prolong Pharmaceuticals

11.10.1 Prolong Pharmaceuticals Company Details

11.10.2 Prolong Pharmaceuticals Business Overview

11.10.3 Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction

11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.10.5 Prolong Pharmaceuticals Recent Development

11.11 Modus Therapeutics

11.11.1 Modus Therapeutics Company Details

11.11.2 Modus Therapeutics Business Overview

11.11.3 Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Introduction

11.11.4 Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.11.5 Modus Therapeutics Recent Development

11.12 Sangamo Biosciences

11.12.1 Sangamo Biosciences Company Details

11.12.2 Sangamo Biosciences Business Overview

11.12.3 Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Introduction

11.12.4 Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.12.5 Sangamo Biosciences Recent Development

11.13 Bioverativ

11.13.1 Bioverativ Company Details

11.13.2 Bioverativ Business Overview

11.13.3 Bioverativ Sickle Cell Disease Diagnosis and Treatment Introduction

11.13.4 Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.13.5 Bioverativ Recent Development

11.14 Imara

11.14.1 Imara Company Details

11.14.2 Imara Business Overview

11.14.3 Imara Sickle Cell Disease Diagnosis and Treatment Introduction

11.14.4 Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.14.5 Imara Recent Development

11.15 Ironwood Pharmaceuticals

11.15.1 Ironwood Pharmaceuticals Company Details

11.15.2 Ironwood Pharmaceuticals Business Overview

11.15.3 Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Introduction

11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

11.15.5 Ironwood Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Global Blood Therapeutics

Micelle BioPharma

Bluebird bio

Prolong Pharmaceuticals

Ironwood Pharmaceuticals

List of Tables

Table 1. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Diagnosis

Table 3. Key Players of Treatment

Table 4. Global Sickle Cell Disease Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2020-2025)

Table 8. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2026-2031)

Table 10. Sickle Cell Disease Diagnosis and Treatment Market Trends

Table 11. Sickle Cell Disease Diagnosis and Treatment Market Drivers

Table 12. Sickle Cell Disease Diagnosis and Treatment Market Challenges

Table 13. Sickle Cell Disease Diagnosis and Treatment Market Restraints

Table 14. Global Sickle Cell Disease Diagnosis and Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players (2020-2025)

Table 16. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2024)

Table 17. Ranking of Global Top Sickle Cell Disease Diagnosis and Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Headquarters and Area Served

Table 20. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Product and Application

Table 21. Global Key Players of Sickle Cell Disease Diagnosis and Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Sickle Cell Disease Diagnosis and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Sickle Cell Disease Diagnosis and Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Emmaus Medical Company Details

Table 47. Emmaus Medical Business Overview

Table 48. Emmaus Medical Sickle Cell Disease Diagnosis and Treatment Product

Table 49. Emmaus Medical Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 50. Emmaus Medical Recent Development

Table 51. Addmedica Company Details

Table 52. Addmedica Business Overview

Table 53. Addmedica Sickle Cell Disease Diagnosis and Treatment Product

Table 54. Addmedica Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 55. Addmedica Recent Development

Table 56. Gamida Cell Company Details

Table 57. Gamida Cell Business Overview

Table 58. Gamida Cell Sickle Cell Disease Diagnosis and Treatment Product

Table 59. Gamida Cell Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 60. Gamida Cell Recent Development

Table 61. GlycoMimetics Company Details

Table 62. GlycoMimetics Business Overview

Table 63. GlycoMimetics Sickle Cell Disease Diagnosis and Treatment Product

Table 64. GlycoMimetics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 65. GlycoMimetics Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Sickle Cell Disease Diagnosis and Treatment Product

Table 69. Pfizer Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. Novartis Company Details

Table 72. Novartis Business Overview

Table 73. Novartis Sickle Cell Disease Diagnosis and Treatment Product

Table 74. Novartis Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. Global Blood Therapeutics Company Details

Table 77. Global Blood Therapeutics Business Overview

Table 78. Global Blood Therapeutics Sickle Cell Disease Diagnosis and Treatment Product

Table 79. Global Blood Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 80. Global Blood Therapeutics Recent Development

Table 81. Micelle BioPharma Company Details

Table 82. Micelle BioPharma Business Overview

Table 83. Micelle BioPharma Sickle Cell Disease Diagnosis and Treatment Product

Table 84. Micelle BioPharma Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 85. Micelle BioPharma Recent Development

Table 86. Bluebird Bio Company Details

Table 87. Bluebird Bio Business Overview

Table 88. Bluebird Bio Sickle Cell Disease Diagnosis and Treatment Product

Table 89. Bluebird Bio Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 90. Bluebird Bio Recent Development

Table 91. Prolong Pharmaceuticals Company Details

Table 92. Prolong Pharmaceuticals Business Overview

Table 93. Prolong Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product

Table 94. Prolong Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 95. Prolong Pharmaceuticals Recent Development

Table 96. Modus Therapeutics Company Details

Table 97. Modus Therapeutics Business Overview

Table 98. Modus Therapeutics Sickle Cell Disease Diagnosis and Treatment Product

Table 99. Modus Therapeutics Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 100. Modus Therapeutics Recent Development

Table 101. Sangamo Biosciences Company Details

Table 102. Sangamo Biosciences Business Overview

Table 103. Sangamo Biosciences Sickle Cell Disease Diagnosis and Treatment Product

Table 104. Sangamo Biosciences Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 105. Sangamo Biosciences Recent Development

Table 106. Bioverativ Company Details

Table 107. Bioverativ Business Overview

Table 108. Bioverativ Sickle Cell Disease Diagnosis and Treatment Product

Table 109. Bioverativ Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 110. Bioverativ Recent Development

Table 111. Imara Company Details

Table 112. Imara Business Overview

Table 113. Imara Sickle Cell Disease Diagnosis and Treatment Product

Table 114. Imara Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 115. Imara Recent Development

Table 116. Ironwood Pharmaceuticals Company Details

Table 117. Ironwood Pharmaceuticals Business Overview

Table 118. Ironwood Pharmaceuticals Sickle Cell Disease Diagnosis and Treatment Product

Table 119. Ironwood Pharmaceuticals Revenue in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025) & (US$ Million)

Table 120. Ironwood Pharmaceuticals Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

Table 124. Authors List of This Report

List of Figures

Figure 1. Sickle Cell Disease Diagnosis and Treatment Picture

Figure 2. Global Sickle Cell Disease Diagnosis and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Type: 2024 VS 2031

Figure 4. Diagnosis Features

Figure 5. Treatment Features

Figure 6. Global Sickle Cell Disease Diagnosis and Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Application: 2024 VS 2031

Figure 8. Child Case Studies

Figure 9. Adult Case Studies

Figure 10. Sickle Cell Disease Diagnosis and Treatment Report Years Considered

Figure 11. Global Sickle Cell Disease Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Sickle Cell Disease Diagnosis and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Region: 2024 VS 2031

Figure 14. Global Sickle Cell Disease Diagnosis and Treatment Market Share by Players in 2024

Figure 15. Global Top Sickle Cell Disease Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Diagnosis and Treatment as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Disease Diagnosis and Treatment Revenue in 2024

Figure 17. North America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 19. United States Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 23. Germany Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Sickle Cell Disease Diagnosis and Treatment Market Share by Region (2020-2031)

Figure 31. China Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 39. Mexico Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Sickle Cell Disease Diagnosis and Treatment Market Share by Country (2020-2031)

Figure 43. Turkey Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Sickle Cell Disease Diagnosis and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Emmaus Medical Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 47. Addmedica Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 48. Gamida Cell Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 49. GlycoMimetics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 52. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 53. Micelle BioPharma Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 54. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 55. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 56. Modus Therapeutics Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 57. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 58. Bioverativ Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 59. Imara Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 60. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Diagnosis and Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-13C13054

Fri Mar 21 00:00:00 UTC 2025

$8500

Enterprise User

Add to Cart

Global Sickle Cell Anemia Testing Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36I12524

Mon Mar 10 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18M13082

Fri Mar 07 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Marfan Syndrome Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18L9349

Tue Mar 04 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-18M13082

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

FEATURED COMPANIES

Sickle Cell Disease Diagnosis and Treatment Market Size

Sickle Cell Disease Diagnosis and Treatment Market

Scope of Sickle Cell Disease Diagnosis and Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Sickle Cell Disease Diagnosis and Treatment Market report?

What are the Application segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

What are the Type segmentation covered in the Sickle Cell Disease Diagnosis and Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS

$8500

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User